Andere talen MiMedx Group, Inc.

Aandelen

MDXG

US6024961012

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,16 ^USD	-2,69%		-6,81%	-29,76%

27/03	MiMedx Group zegt dat de FDA bevestigt dat Axiofill niet voldoet aan de wettelijke normen voor op weefsel gebaseerde producten	MT
27/03	MiMedx Group, Inc. Geeft update over AXIOFILL Request for Designation (RFD) van FDA	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30	16/04
MIMEDX Provides Update on AXIOFILL Request for Designation from FDA	28/03
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024	27/03
MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products	27/03
MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit	27/03
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA	27/03
MiMedx Group, Inc. Provides Update on AXIOFILL Request for Designation from FDA	27/03
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	20/03
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	20/03
MiMedx Launches E-Commerce Platform	13/03
MIMEDX Introduces E-Commerce and Account Management Platform	13/03
Mimedx Introduces E-Commerce and Account Management Platform	13/03
MIMEDX Announces Appointment of Two New Independent Directors	04/03
MiMedx Group, Inc. Announces Appointment of New Independent Directors	04/03
Spectral AI Names Peter Carlson Chief Executive Officer; Reaffirms 2024 Preliminary Revenue Guidance	01/03
MiMedx: Q4 Earnings Snapshot	28/02
Earnings Flash (MDXG) MIMEDX GROUP Posts Q4 Revenue $86.8M, vs. Street Est of $85.2M	28/02
Earnings Flash (MDXG) MIMEDX GROUP Reports Q4 EPS $0.04, vs. Street Est of $0.06	28/02
MiMedx Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results	28/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen MiMedx Group, Inc.

Aandelen

MDXG

US6024961012

Andere talen

Filters